Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection

J Hepatol. 2017 Jun;66(6):1282-1299. doi: 10.1016/j.jhep.2017.02.010. Epub 2017 Feb 20.
No abstract available

Keywords: DAAs; Extrahepatic manifestations; Hepatitis C virus; Rituximab.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / therapy
  • Cryoglobulinemia / etiology
  • Cryoglobulinemia / therapy
  • Evidence-Based Medicine
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Interferons / therapeutic use
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / therapy
  • Ribavirin / therapeutic use
  • Rituximab / therapeutic use
  • Vasculitis / etiology
  • Vasculitis / therapy

Substances

  • Antiviral Agents
  • Ribavirin
  • Rituximab
  • Interferons